So far, no patient has needed further treatment.
In an unprecedented clinical trial, a dozen rectal cancer patients saw their tumors disappear after they received an experimental drug called dostarlimab, and none of the patients experienced significant side effects from the treatment.
"I believe this is the first time this has happened in the history of cancer ," in that this is the first cancer trial in which every patient entered remission, Dr. Luis Alberto Diaz, Jr., one of the trial leaders and a medical oncologist at Memorial Sloan…
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
NPR Cookie Consent and Choices
Leer más »
Every Single Patient in This Small Experimental Drug Trial Saw Their Cancer DisappearIn what appears to be a very promising breakthrough for the treatment of rectal cancer, a small drug trial conducted in the US found every patient treated in the experiment had their cancer successfully go into remission.
Leer más »
Small Rectal Cancer Study Has Remission in Every PatientA small clinical trial with 12 rectal cancer patients found remission in 100% of them, according to a new paper published in The New England Journal of Medicine.
Leer más »
Small Cancer Trial Delivers ‘Unheard-of' Result: Complete Remission for EveryoneA small NYC-led cancer trial has achieved a result reportedly never before seen – the total remission of cancer in all of its patients. To be sure, the trial — led by doctors at Memorial Sloan Kettering and backed by drug maker GlaxoSmithKline — has only completed treatment of 12 patients, with a specific cancer in its early stages and…
Leer más »
Breast cancer drug shows promise, opens new treatment possibilities to thousands of patientsFor the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.
Leer más »
Breast cancer drug shows promise, opens new treatment possibilities to thousands of patientsFor the first time, a drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.
Leer más »